Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 1 art units • 1 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Harbinger Health Inc. has 4 pending office actions currently active in the Biotechnology & Pharmaceuticals technology area. All 4 pending office actions are assigned to 1 distinct examiner, HASAN, KHALEDA B. This represents a high level of examiner concentration, as HASAN, KHALEDA B is also the busiest examiner with 4 busiest examiner pending actions. The entire active portfolio is therefore subject to the review of a single individual.
The data also shows that these actions are contained within 1 distinct art unit. For the practitioner, this means that the 4 pending office actions are not only limited to one person's perspective but are also confined to the procedural norms of 1 distinct art unit. There is no opportunity to compare examiner behavior across the 4 pending office actions. Success in the Biotechnology & Pharmaceuticals sector for this company depends on successfully navigating the specific requirements of the 4 busiest examiner pending actions held by HASAN, KHALEDA B.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HASAN, KHALEDA B | 4 | 59.4% | +49.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18519589 | SOLID PHASE NEGATIVE ENRICHMENT | HASAN, KHALEDA B | — |
| 18385649 | BODILY FLUID TARGET ENRICHMENT | HASAN, KHALEDA B | — |
| 18131634 | SOLID PHASE NEGATIVE ENRICHMENT | HASAN, KHALEDA B | — |
| 18121328 | BODILY FLUID TARGET ENRICHMENT | HASAN, KHALEDA B | — |
| Art Unit | Apps |
|---|---|
| 1636 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18519589 | SOLID PHASE NEGATIVE ENRICHMENT | HASAN, KHALEDA B | — | §103§112DP | Non-Final OA | — | Pending | Nov 27, 2023 |
| 18385649 | BODILY FLUID TARGET ENRICHMENT | HASAN, KHALEDA B | 1636 | §103§112DP | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18131634 | SOLID PHASE NEGATIVE ENRICHMENT | HASAN, KHALEDA B | 1636 | §103DP | Non-Final OA | — | Pending | Apr 06, 2023 |
| 18121328 | BODILY FLUID TARGET ENRICHMENT | HASAN, KHALEDA B | 1636 | §103§112DP | Non-Final OA | — | Pending | Mar 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial